These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 7518157

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study.
    Masri MA, Shakuntala V, Dhawan IK, Zahir M, Shanwaz M, Hayes K, Pingle A.
    Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889
    [No Abstract] [Full Text] [Related]

  • 23. Prolonged renal allograft survival in chronic rejection by conversion to triple therapy.
    Beckingham IJ, Dennis MJ, Innes A, Burden RP, Morgan AG, Bishop MC.
    Transplant Proc; 1993 Apr; 25(2):2100. PubMed ID: 8470283
    [No Abstract] [Full Text] [Related]

  • 24. The therapeutic window of cyclosporine in Chinese recipients of renal transplantation.
    Guan D, Wang R, Lu J, Wang M, Xu C.
    Transplant Proc; 1995 Feb; 27(1):850-1. PubMed ID: 7879203
    [No Abstract] [Full Text] [Related]

  • 25. A mathematical equation to differentiate overload proteinuria from tubulo-interstitial involvement in glomerular diseases.
    Hofmann W, Edel H, Guder WG.
    Clin Nephrol; 1995 Jul; 44(1):28-31. PubMed ID: 7554530
    [Abstract] [Full Text] [Related]

  • 26. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR, Russell WC, Gaber LW, Amiri MH, Vera SR, Gaber AO.
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy.
    Maachi K, Berthoux P, Burgard G, Alamartine E, Berthoux F.
    Transplant Proc; 1995 Feb; 27(1):846-9. PubMed ID: 7879202
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cyclosporine levels impact early rejection episodes.
    Granger DK, Amin NB, Sorenson AL, Gillingham KJ, Canafax DM, Matas AJ.
    Transplant Proc; 1994 Oct; 26(5):2513. PubMed ID: 7940771
    [No Abstract] [Full Text] [Related]

  • 32. Follow-up of 29 kidney transplant recipients having more than 20 years of functioning allografts.
    Fonseca JA, Ianhez LE, Azevedo LS, Sabbaga E.
    Transplant Proc; 1992 Oct; 24(5):1863-4. PubMed ID: 1412886
    [No Abstract] [Full Text] [Related]

  • 33. Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.
    Vanrenterghem Y, Peeters J.
    Transplant Proc; 1996 Aug; 28(4):2097-9. PubMed ID: 8769165
    [No Abstract] [Full Text] [Related]

  • 34. Safety and efficacy of long-term cyclosporine-ketoconazole administration and preliminary results of a randomized trial.
    First MR, Schroeder TJ, Michael A, Hariharan S, Weiskittel P, Alexander JW.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):591-4. PubMed ID: 8438428
    [No Abstract] [Full Text] [Related]

  • 35. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
    Ghoneim MA, Sobh MA, Shokeir AA, Bakr MA, el-Sherif A, Foda MA.
    Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
    [No Abstract] [Full Text] [Related]

  • 36. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years.
    Thiel G, Bock A, Spöndlin M, Brunner FP, Mihatsch M, Rufli T, Landmann J.
    Transplant Proc; 1994 Oct; 26(5):2493-8. PubMed ID: 7940765
    [Abstract] [Full Text] [Related]

  • 37. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T, Kapischke M, Busing M.
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [Abstract] [Full Text] [Related]

  • 38. Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy.
    Hiesse C, Rousseau P, Kriaa F, Larue JR, Charpentier B.
    Transplant Proc; 1995 Feb; 27(1):1066-7. PubMed ID: 7878807
    [No Abstract] [Full Text] [Related]

  • 39. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP, van den Brand JA, Wetzels JF.
    Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
    [Abstract] [Full Text] [Related]

  • 40. [Usefulness of determining urinary markers of early renal damage for monitoring nephrotoxicity during occupational exposure to mercury vapors].
    Rutowski J, Moszczyński P, Bem S, Szewczyk A.
    Med Pr; 1998 Feb; 49(2):129-35. PubMed ID: 9695060
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.